AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home hLife Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Article | Open Access

Structural insights into the distinct protective mechanisms of human antibodies targeting ZIKV NS1

Qi Pan1,#Xiaomin Xing2,#Jianhai Yu3,#Qiang Chen1,#Haizhan Jiao1Wanqin Zhang1Yingfen Wen2Ming Gao2Wei Zhao3( )Lei Yu2( )Hongli Hu1( )
Kobilka Institute of Innovative Drug Discovery, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China
Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangdong, China
BSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangdong, China

#These authors contributed equally to this work

Show Author Information

Highlights

● Group Ⅰ antibodies (3G2 and 4B8) recognize the previously unreported epitopes on the outer surface of the Zika virus (ZIKV) NS1 dimer.

● Group Ⅱ antibodies (4F10, 2E11, and 14G5) recognize the common epitopes at the distal end of the ZIKV NS1 β-ladder domain.

● Group Ⅰ antibodies have stronger recognition of the cell surface form of NS1, and their immunoglobulin G (IgG) and Fab completely inhibit the endothelial permeability caused by ZIKV sNS1 proteins.

● The blockade efficiency of Group Ⅱ antibodies is related to their affinity for the ZIKV sNS1 protein and the presence of full-length IgG.

Abstract

Antibodies targeting non-structural protein 1 (NS1) confer protection against Zika virus (ZIKV). Although monoclonal antibodies (MAbs) 3G2 and 4B8 are more potent than MAb 4F10 in suppressing ZIKV infection in neonatal mice models, the epitopes are unclear. Herein, we determined the Cryo-electron microscopy (Cryo-EM) structures of ZIKV NS1 in complex with five human antibodies at 2.6–2.9 Å resolution. Group Ⅰ antibodies (3G2 and 4B8) recognize the previously unreported epitopes on the outer surface of the NS1 dimer. The unique binding mode of Group Ⅰ antibodies led to a stronger recognition of the cell surface form of NS1 and completely inhibited secreted form non-structural protein 1 (sNS1)-induced endothelial permeability via their immunoglobulin G (IgG) and Fab. Group Ⅱ antibodies (4F10, 2E11, and 14G5) recognize common epitopes in the distal end of the β-ladder domain, with a blockade efficiency that may be related to their affinity for the sNS1 protein and the presence of full-length IgG. These findings elucidate the correlation between epitope recognition and protective efficacy of anti-NS1 antibodies and highlight the diagnostic and therapeutic potential of 3G2 and 4B8.

Graphical Abstract

References

【1】
【1】
 
 
hLife
Pages 527-541

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Pan Q, Xing X, Yu J, et al. Structural insights into the distinct protective mechanisms of human antibodies targeting ZIKV NS1. hLife, 2024, 2(10): 527-541. https://doi.org/10.1016/j.hlife.2024.05.003

799

Views

6

Crossref

Received: 10 March 2024
Revised: 11 May 2024
Accepted: 11 May 2024
Published: 16 May 2024
© 2024 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).